The biological basis of behavioral symptoms in dementia.
作者信息
Garand L, Buckwalter K C, Hall G R
机构信息
College of Nursing, University of Iowa, Iowa City 52242, USA.
出版信息
Issues Ment Health Nurs. 2000 Jan-Feb;21(1):91-107. doi: 10.1080/016128400248284.
Abstract
This article describes the pathophysiology of dementia and differentiates between cognitive and noncognitive symptoms that characterize this devastating illness. Relationships between brain anatomic and neurochemical systems and behavioral symptoms of dementia are discussed. An overview of the etiologies and neuro-pathologies of dementia are presented as they relate to impairments in memory and intellectual abilities, personality changes, and behavioral symptoms. Recent genetic and molecular discoveries that have advanced our understanding of this complex spectrum of disorders and their treatment(s) are also highlighted.
摘要
相似文献
1
The biological basis of behavioral symptoms in dementia.
Issues Ment Health Nurs. 2000 Jan-Feb;21(1):91-107. doi: 10.1080/016128400248284.
2
Approaches to memory loss in neuropsychiatric disorders.
Semin Clin Neuropsychiatry. 2000 Oct;5(4):259-65. doi: 10.1053/scnp.2000.16528.
3
Psychiatric and behavioral symptoms in Alzheimer's disease and other dementias: etiology and management.
Curr Neurol Neurosci Rep. 2005 Sep;5(5):345-54. doi: 10.1007/s11910-005-0058-4.
4
Newest developments in dementia treatment and prevention.
Geriatr Nurs. 2001 Jul-Aug;22(4):216, 218. doi: 10.1067/mgn.2001.117920.
5
WITHDRAWN: Tacrine for Alzheimer's disease.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD000202. doi: 10.1002/14651858.CD000202.
6
Guidelines for the use of tacrine in Alzheimer's disease: clinical application and effectiveness. Johns Hopkins Dementia Research Clinic.
J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):67-73. doi: 10.1176/jnp.8.1.67.
7
Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.
J Neural Transm (Vienna). 2004 Oct;111(10-11):1287-301. doi: 10.1007/s00702-004-0178-z. Epub 2004 Jul 7.
8
Pharmacological management of behavioural and psychological disturbance in dementia.
Hum Psychopharmacol. 2006 Jan;21(1):1-12. doi: 10.1002/hup.745.
9
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
Alzheimers Dement. 2013 Sep;9(5):488-98. doi: 10.1016/j.jalz.2012.06.010. Epub 2012 Nov 14.
10
New cholinergic therapies: treatment tools for the psychiatrist.
J Clin Psychiatry. 1998;59 Suppl 13:31-5.
引用本文的文献
1
Psychosocial and Environmental Treatment Approaches for Behavioral and Psychological Symptoms in Neurocognitive Disorders: an Update and Future Directions.
Curr Treat Options Psychiatry. 2017 Mar;4(1):80-101. doi: 10.1007/s40501-017-0105-1. Epub 2017 Feb 6.
2
Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases.
Front Neurosci. 2020 Apr 30;14:305. doi: 10.3389/fnins.2020.00305. eCollection 2020.
3
Neuropsychiatric symptom profiles of community-dwelling persons living with dementia: Factor structures revisited.
Int J Geriatr Psychiatry. 2020 Sep;35(9):1009-1020. doi: 10.1002/gps.5323. Epub 2020 May 26.
4
The "Violent Resident": A Critical Exploration of the Ethics of Resident-to-Resident Aggression.
J Bioeth Inq. 2019 Jun;16(2):173-183. doi: 10.1007/s11673-019-09898-1. Epub 2019 Feb 11.
5
Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.
Eur J Clin Pharmacol. 2017 Nov;73(11):1389-1398. doi: 10.1007/s00228-017-2314-3. Epub 2017 Aug 5.
6
Dementia-related restlessness: relationship to characteristics of persons with dementia and family caregivers.
Int J Geriatr Psychiatry. 2018 Jan;33(1):185-192. doi: 10.1002/gps.4705. Epub 2017 Mar 23.
7
Towards defining restlessness in individuals with dementia.
Aging Ment Health. 2017 May;21(5):543-552. doi: 10.1080/13607863.2015.1128880. Epub 2016 Jan 8.
本文引用的文献
1
Development and testing of the Resistiveness to Care Scale.
Res Nurs Health. 1999 Feb;22(1):27-38. doi: 10.1002/(sici)1098-240x(199902)22:1<27::aid-nur4>3.0.co;2-t.
2
What's hot, what's not, in dementia drugs. Part II.
J Gerontol Nurs. 1997 Dec;23(12):46-7. doi: 10.3928/0098-9134-19971201-11.
3
What's hot, what's not, in dementia drugs? Part I: Cholinergic therapies.
J Gerontol Nurs. 1997 Sep;23(9):52-4. doi: 10.3928/0098-9134-19970901-12.
4
Interventions for cognitive impairment and neurobehavioral disturbances of older adults.
Annu Rev Nurs Res. 1997;15:35-56.
5
CERAD behavior rating scale for dementia.
Int Psychogeriatr. 1996;8 Suppl 3:317-20; discussion 351-4. doi: 10.1017/s1041610297003542.
6
Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease.
Alzheimer Dis Assoc Disord. 1994;8 Suppl 3:54-60.
7
The influence of environmental factors in incidents of disruptive behavior.
J Gerontol Nurs. 1995 May;21(5):19-24. doi: 10.3928/0098-9134-19950501-06.
8
"Free radicals" are not a 60's rock group.
J Gerontol Nurs. 1995 Oct;21(10):3-4. doi: 10.3928/0098-9134-19951001-03.
9
Preventing violent behavior. An integrated theoretical model for nursing.
Perspect Psychiatr Care. 1983 Apr-Jun;21(2):54-8.
10
Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
J Clin Psychiatry. 1987 May;48 Suppl:9-15.
Zotero 插件